Cell Pathways Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$79M
Cell Pathways General Information
Description
Developer of products for the treatment and prevention of precancerous lesions and cancer of colon and lung. The company aims in cancer treatment and prevention and to build a pharmaceutical company focused on the oncology market.
Contact Information
Website
www.cellpathways.comCorporate Office
- 702 Electronic Drive
- Horsham, PA 19044
- United States
Corporate Office
- 702 Electronic Drive
- Horsham, PA 19044
- United States
Cell Pathways Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 12-Jun-2003 | $79M | Completed | Generating Revenue | ||
| 2. PIPE | 09-Nov-2000 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series F) | 04-Jun-1997 | $17.5M | $17.5M | Completed | Generating Revenue |
Cell Pathways Patents
Cell Pathways Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2002356131-A1 | Treatment for cystic fibrosis | Inactive | 24-Aug-2001 | ||
| EP-1435782-A1 | Treatment for cystic fibrosis | Inactive | 24-Aug-2001 | ||
| WO-2003017765-A1 | Treatment for cystic fibrosis | Inactive | 24-Aug-2001 | ||
| AU-2002356130-A1 | Treatment for lupus erythematosus | Inactive | 23-Aug-2001 | ||
| EP-1435961-A2 | Treatment for lupus erythematosus | Inactive | 23-Aug-2001 | A61K31/165 |
Cell Pathways Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BlueGem Capital Partners | PE/Buyout | Minority | ||
| Canaan Partners | Venture Capital | Minority | ||
| Cercano Management | PE/Buyout | Minority | ||
| DMW (Cyprus) | Venture Capital | Minority | ||
| Jackson Capital Management | PE/Buyout | Minority |
Cell Pathways FAQs
-
When was Cell Pathways founded?
Cell Pathways was founded in 1989.
-
Where is Cell Pathways headquartered?
Cell Pathways is headquartered in Horsham, PA.
-
What industry is Cell Pathways in?
Cell Pathways’s primary industry is Drug Discovery.
-
Is Cell Pathways a private or public company?
Cell Pathways is a Private company.
-
What is the current valuation of Cell Pathways?
The current valuation of Cell Pathways is .
-
What is Cell Pathways’s current revenue?
The current revenue for Cell Pathways is .
-
How much funding has Cell Pathways raised over time?
Cell Pathways has raised $41.1M.
-
Who are Cell Pathways’s investors?
BlueGem Capital Partners, Canaan Partners, Cercano Management, DMW (Cyprus), and Jackson Capital Management are 5 of 13 investors who have invested in Cell Pathways.
-
When was Cell Pathways acquired?
Cell Pathways was acquired on 12-Jun-2003.
-
Who acquired Cell Pathways?
Cell Pathways was acquired by OSI Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process